New
We are pleased to announce that John E. Harris, M.D., Ph.D., a distinguished vitiligo investigator from University of Massachusetts, was awarded with a grant by Dermatology Foundation to continue research on Skin-Resident Memory T Cells in Vitiligo. Last year, VRF has supported John Harris' project that aims to test some new substances for vitiligo treatment using his unique mouse model of vitiligo. If successful, this could be a critical step towards developing a new approach to vitiligo treatment.
FAQOther Questions
- Vitiligo and hearing loss: any connection?
Vitiligo is primarily recognized for causing skin discoloration, but it can also impact melanocytes in unexpected areas, such as the inner ear. This raises questions about wheth...
- Polypodium leucotomos as an adjunct treatment for vitiligo?
The tropical fern Polypodium leucotomos (also known as Polypodium aureum) and its relative Polypodium decumanumhave shown potential benefits for managing vitiligo and other auto...
- Awareness Days Similar to World Vitiligo Day
World Vitiligo Day, celebrated annually on June 25 since 2012, is a significant event dedicated to raising awareness about vitiligo and supporting those affected by the conditio...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.